Valuation Metrics Signal Elevated Price Levels
As of the latest assessment, CRISIL’s price-to-earnings (P/E) ratio stands at 39.29, a significant premium compared to historical averages and peer benchmarks within the Capital Markets industry. This elevated P/E ratio suggests that investors are currently paying nearly 40 times the company’s earnings, reflecting high expectations for future growth but also signalling stretched valuations.
Complementing this, the price-to-book value (P/BV) ratio has surged to 9.92, underscoring the market’s willingness to pay almost ten times the book value of the company’s equity. Such a high P/BV ratio is indicative of strong investor confidence but also raises concerns about potential overvaluation, especially when contrasted with mid-cap peers where P/BV ratios typically range between 3 and 6.
Other valuation multiples reinforce this narrative of premium pricing. The enterprise value to EBITDA (EV/EBITDA) ratio is at 27.37, and the EV to EBIT ratio is 31.09, both well above sector averages. These multiples suggest that CRISIL’s operational earnings are being valued at a steep premium, which may limit upside potential unless earnings growth accelerates substantially.
Financial Performance and Returns Contextualise Valuation
CRISIL’s return on capital employed (ROCE) remains robust at 40.73%, while return on equity (ROE) is a healthy 25.25%. These figures highlight the company’s efficient capital utilisation and strong profitability, which partly justify the premium valuation. Additionally, the dividend yield of 2.11% offers a modest income component to investors, though it is not a primary driver of the stock’s appeal.
However, when analysing stock returns relative to the Sensex, CRISIL’s performance presents a nuanced picture. Over the past week, the stock outperformed the benchmark with a 10.58% gain versus Sensex’s 5.77%. Yet, over the one-month and year-to-date periods, CRISIL lagged behind, posting returns of -3.29% and -5.20% respectively, compared to the Sensex’s -0.84% and -9.00%. Over longer horizons, the stock has delivered strong absolute returns, with a five-year gain of 122.69% outpacing the Sensex’s 56.38%, though the ten-year return of 110.57% trails the Sensex’s 214.30%.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
Mojo Score and Grade Reflect Caution
Reflecting these valuation concerns and mixed performance, CRISIL’s Mojo Score currently stands at 37.0, categorising it as a Sell. This represents a downgrade from its previous Hold rating as of 22 September 2025. The shift in Mojo Grade from Hold to Sell signals a more cautious stance from analysts, who are wary of the stock’s stretched valuation metrics and the risk of limited upside in the near term.
CRISIL’s market capitalisation is classified as mid-cap, which typically entails higher volatility and sensitivity to market sentiment compared to large-cap stocks. The stock’s recent day change of 4.46% indicates active trading interest, but investors should weigh this against the broader valuation context and sector dynamics.
Comparative Valuation and Industry Positioning
Within the Capital Markets sector, CRISIL’s valuation multiples are notably higher than many peers, positioning it as one of the most expensive stocks in its category. The PEG ratio of 3.28 further emphasises this premium, suggesting that the stock’s price growth is outpacing earnings growth by a considerable margin. Typically, a PEG ratio above 1.5 is considered expensive, and CRISIL’s figure more than doubles this threshold.
Such valuation levels imply that investors are pricing in sustained high growth and profitability, which may be challenging to maintain given competitive pressures and macroeconomic uncertainties. While CRISIL’s strong ROCE and ROE metrics support its quality credentials, the risk of valuation contraction remains if growth expectations are not met.
Considering CRISIL Ltd.? Wait! SwitchER has found potentially better options in Capital Markets and beyond. Compare this mid-cap with top-rated alternatives now!
- - Better options discovered
- - Capital Markets + beyond scope
- - Top-rated alternatives ready
Price Action and Trading Range Insights
CRISIL’s current stock price is ₹4,100.15, up from the previous close of ₹3,925.05, reflecting a daily gain of 4.46%. The intraday trading range has been between ₹3,944.55 and ₹4,117.00. Despite this recent uptick, the stock remains well below its 52-week high of ₹6,329.95, indicating a significant correction from peak levels. The 52-week low stands at ₹3,893.85, placing the current price just above this floor.
This price behaviour suggests that while there is renewed buying interest, possibly driven by short-term catalysts or market sentiment, the stock is still grappling with valuation pressures and profit-taking from earlier highs. Investors should monitor whether the stock can sustain gains above the ₹4,000 mark or if it faces resistance near the mid-term trading range.
Investment Implications and Outlook
For investors, CRISIL’s transition to a very expensive valuation grade warrants careful consideration. The company’s strong profitability and capital efficiency metrics are positives, but the premium multiples imply limited margin for error. Any slowdown in earnings growth or adverse sector developments could trigger valuation re-rating and price corrections.
Given the current Mojo Grade of Sell and the downgrade from Hold, a cautious approach is advisable. Investors seeking exposure to the Capital Markets sector might consider diversifying into stocks with more attractive valuations or stronger momentum profiles. The mixed return performance relative to the Sensex further underscores the need for selective stock picking within this space.
Summary
In summary, CRISIL Ltd. remains a high-quality mid-cap stock with robust financial metrics, but its valuation has stretched to very expensive levels. The elevated P/E, P/BV, and EV/EBITDA multiples, combined with a high PEG ratio, suggest that the market is pricing in significant growth expectations. However, recent relative underperformance and a downgrade in Mojo Grade to Sell highlight the risks associated with these lofty valuations. Investors should weigh these factors carefully when considering CRISIL as part of their portfolio strategy.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
